Price
$5.69-44.00%Social Signal Score
Analyst Ratings
12 analystsRevenue
$740.31M+1001.08%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Suzanne Foster
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 10,900
- Beta
- 1.39
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 0.51
Financials
Revenue
$740.31M+1001.1%Net Income
$-133.93M-60884.8%EBITDA
$-16.18MFree Cash Flow
$-20.94M-353.8%EPS (diluted)
$-0.99-14043.7%Shares Outstanding (diluted)
136.12M+335.6%Operating Expenses
$96.09MCash & Debt
$43.29MReturn of Capital
$0.00Revenue by Segment (annual)
$691.16MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.24B | $-70.79M | $-0.52 |
| 2024 | $3.26B | $90.42M | $0.62 |
| 2023 | $3.20B | $-678.89M | $-5.32 |
| 2022 | $2.97B | $69.32M | $0.52 |
| 2021 | $2.45B | $156.18M | $1.12 |
| 2020 | $1.06B | $-161.63M | $-1.23 |
| 2019 | $529.64M | $-21.34M | $-0.29 |
| 2018 | $345.28M | $2.09M | $0.07 |
| 2017 | $192.56M | $-693.00 | $-0.00 |
| 2016 | $174.32M | $-3.79M | $-0.12 |
Valuation
AHCOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80+60.00%Social Signal Score
Mentions (5)
- Newsbusinesswire.com·24d ago·Negative
AdaptHealth To Participate in Upcoming Investor Conferences PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today announced today that they will participate in the following upcoming investor conferences: The 2026 Jefferies Healthcare Services and Technology Conference, being he…
View source ↗ - Newsglobenewswire.com·52d ago·Neutral
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information CONSHOHOCKEN, Pa., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the AdaptHealth Corp. (Nasdaq: AHCO) data breach.
View source ↗ - Newsmarketbeat.com·55d ago·Negative
AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth AdaptHealth NASDAQ: AHCO executives outlined the company's second-quarter performance, portfolio changes and plans to focus capital on sleep, respiratory and home medical equipment businesses during a Canaccord conference discussion.
View source ↗ - Newsfool.com·57d ago·Negative
Why AdaptHealth Stock Plummeted This Week AdaptHealth posted a huge earnings miss in Q2, and sales also came in below expectations. The company also lowered its fiscal performance targets for the year.
View source ↗ - Newsbusinesswire.com·58d ago·Negative
AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $AHCO--AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law.
View source ↗
Earnings
Tue, Nov 3(in 4 weeks)
Consensus estimate $-0.05 per share
Typical surprise -20.6% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$0.06 vs $0.17miss
- Tue, May 5$-0.06 vs $0.01miss
- Tue, Feb 24$0.27 vs $0.34miss
- Tue, Nov 4$0.22 vs $0.24miss
- Tue, Aug 5$0.01 vs $0.15miss
- Tue, May 6$0.01 vs $0.01beat
Estimates and results for AHCO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by AHCO officers and directors.
- Bought
- $49.3m
- Sold
- $2.5m
16 trades
11 trades
- Wolf Dale Bbought
- Wolf Dale Bbought
- Samet Kenneth Abought
- Wolf Dale Bbought
- Schuster Iii Russell E.sold
- Schuster Iii Russell E.sold
- Oep Vii Gp, L.l.c.bought
- Cashin Richard M Jrbought
73 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Susie Leehouse · NV03 · disclosed Dec 29, 2022 (29d later)Sell$1,001 - $15,000
- Kevin Hernhouse · OK01 · disclosed May 12, 2022 (20d later)Sell$1,001 - $15,000
- Kevin Hernhouse · OK01 · disclosed May 12, 2022 (41d later)Sell$50,001 - $100,000
- Kevin Hernhouse · OK01 · disclosed Jun 15, 2021 (26d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Jun 14, 2021 (19d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Mar 11, 2021 (30d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Mar 11, 2021 (28d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Feb 10, 2021 (19d later)Buy$1,001 - $15,000
- Susie Leehouse · NV03 · disclosed Feb 10, 2021 (36d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.